Blood Pressure Lowering Treatment Trialists C. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625–36.

Article  Google Scholar 

Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 3. Effects in patients at different levels of cardiovascular risk–overview and meta-analyses of randomized trials. J Hypertens. 2014;32:2305–14.

Article  PubMed  CAS  Google Scholar 

D’Agostino RB Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743–53.

Article  PubMed  Google Scholar 

Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB Sr, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63:2935–59.

Article  PubMed  Google Scholar 

SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42:2439–54.

Article  Google Scholar 

Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336:1475–82.

Article  PubMed  PubMed Central  Google Scholar 

Yang X, Li J, Hu D, Chen J, Li Y, Huang J, et al. Predicting the 10-year risks of atherosclerotic cardiovascular disease in chinese population: The China-PAR project (prediction for ASCVD risk in China). Circulation. 2016;134:1430–40.

Article  PubMed  Google Scholar 

Cheng Y, Li Y, Wang J. Ambulatory blood pressure monitoring for the management of hypertension. Chin Med J (Engl). 2022;135:1027–35.

Article  PubMed  CAS  Google Scholar 

Chapman N, Jayasinghe S, Moore MN, Picone DS, Schultz MG, Jose MD, et al. Absolute cardiovascular risk assessment using ‘real world’ clinic blood pressures compared to standardized unobserved and ambulatory methods: an observational study. Hypertens Res. 2024; https://doi.org/10.1038/s41440-024-01841-1.

Roerecke M, Kaczorowski J, Myers MG. Comparing automated office blood pressure readings with other methods of blood pressure measurement for identifying patients with possible hypertension: A systematic review and meta-analysis. JAMA Intern Med. 2019;179:351–62.

Article  PubMed  PubMed Central  Google Scholar 

Lay-Flurrie S, Stevens R, de Leeuw P, Kroon A, Greenfield S, Mohammed M, et al. Using out-of-office blood pressure measurements in established cardiovascular risk scores: a secondary analysis of data from two blood pressure monitoring studies. Br J Gen Pr. 2019;69:e381–8.

Article  Google Scholar 

Guimarães P, Keller A, Böhm M, Lauder L, Fehlmann T, Ruilope LM, et al. Artificial intelligence-derived risk prediction: a novel risk calculator using office and ambulatory blood pressure. Hypertension. 2024. https://doi.org/10.1161/HYPERTENSIONAHA.123.22529.